Prevalence of Vancomycin Resistance in Methicillin-Resistant Staphylococcus Aureus

Authors

  • Abbas Farahani Student ResearchCommittee, Kermanshah University of Medical Sciences, Kermanshah, Iran
  • Abolfazl Davoodabadi Ph.D. Student, Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  • Mohsen Rahnema Student, School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran
  • Omar Ghaderi Student ResearchCommittee, Kermanshah University of Medical Sciences, Kermanshah, Iran
  • Parviz Mohajeri Assistant Professor of Bacteriology, Department of Microbiology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran
Abstract:

Background & Aims: Staphylococcus aureus is one of the most common pathogens in nosocomial infections. Vancomycin is the most important therapeutic drug of choice for treatment of infections caused by methicillin-resistant Staphylococcus aureus (MRSA) strains. Therefore, vancomycin-resistant Staphylococcus aureus (VRSA) or vancomycin-intermediate Staphylococcus aureus (VISA) strains are warnings for the medical community. The aim of this study was to evaluate the prevalence of vancomycin resistance in methicillin-resistant Staphylococcus aureus isolated from the nose of patients hospitalized in Imam Reza Hospital, Kermanshah, Iran. Methods: In the present study, 85 strains of methicillin-resistant Staphylococcus aureus were isolated from patients in Imam Reza Hospital and evaluated for vancomycin resistance with microdilution test, Epsilometer test (E-test), and polymerase chain reaction (PCR). Results: None of the strains were completely resistant to vancomycin; however, 39 strains (45.9%) were diagnosed as hetero-VRSA (hVISA)strains. Conclusion: VISA and VRSA strains were not observed in this study which is a promising finding in the treatment of clinical infections due to Staphylococcus aureus in our society. However, in our study, the prevalence of hVISA strain was 45.9%, which is perhaps a sign of the appearance of more resistant strains (VISA and VRSA) in our country in the future.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Methicillin-Resistant Staphylococcus aureus (MRSA), Vancomycin-Resistant Staphylococcus aureus (VRSA), and Vancomycin-Resistant Enterococci‌ (VRE) contamination of food samples in Iran: A systematic review and meta-analysis

During the last years, antimicrobial resistance has become one of the greatest challenges in clinical settings. Staphylococcus aureus and Enterococcus are important nosocomial pathogens worldwide. In different corners of the world, methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) have been isolated from various sources including different foods of an...

full text

Vancomycin heteroresistance and methicillin-resistant Staphylococcus aureus.

Heteroresistance refers to the presence, within a larger population of fully antimicrobial-susceptible microorganisms, of subpopulations with lesser susceptibility. This phenomenon has been described in a wide range of microorganisms, but much recent attention has been directed toward its expression in Staphylococcus aureus. Although it has long been known that resistance to methicillin is char...

full text

Methicillin-Susceptible, Vancomycin-Resistant Staphylococcus aureus, Brazil.

We report characterization of a methicillin-susceptible, vancomycin-resistant bloodstream isolate of Staphylococcus aureus recovered from a patient in Brazil. Emergence of vancomycin resistance in methicillin-susceptible S. aureus would indicate that this resistance trait might be poised to disseminate more rapidly among S. aureus and represents a major public health threat.

full text

Staphylococcus aureus: methicillin-susceptible S. aureus to methicillin-resistant S. aureus and vancomycin-resistant S. aureus.

The evolution of methicillin-resistant and vancomycin-resistant Staphylococcus aureus has demanded serious review of antimicrobial use and development of new agents and revised approaches to prevent and overcome drug resistance. Depending on local conditions and patient risk factors, empirical therapy of suspected S. aureus infection may require coverage of drug-resistant organisms with newer a...

full text

Prevalence of clindamycin-resistant Staphylococcus aureus induced by macrolide resistance

Introduction: Since the incidence of various infections caused by Staphylococcus aureus increases, the use of effective antibiotics such as clindamycin has been growing to treat the systemic and local infections caused by such organisms. Antibiotic-resistant species are emerging and spreading in today's communities due to misuse of antibiotics and incomplete treatment, turning into a serious ch...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 21  issue 5

pages  394- 404

publication date 2014-12-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023